Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ( (HK:1541) ) has shared an update.
ImmuneOnco Biopharmaceuticals has observed unusual price movements in its shares but confirms that there is no undisclosed information or adverse changes in its business operations and financial position. The company advises shareholders and potential investors to exercise caution when dealing with its shares.
More about ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biopharmaceutical company based in China, focusing on the development of innovative cancer immunotherapies. The company is involved in clinical development and business operations related to biopharmaceuticals.
Average Trading Volume: 4,906,563
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.01B
Learn more about 1541 stock on TipRanks’ Stock Analysis page.